- Home
- PMCB vs FRSX Comparison
PMCB vs FRSX Comparison
Compare PMCB & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- FRSX
- Stock Information
- Founded
- PMCB 1996
- FRSX N/A
- Country
- PMCB United States
- FRSX Israel
- Employees
- PMCB N/A
- FRSX N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- FRSX Computer Software: Prepackaged Software
- Sector
- PMCB Health Care
- FRSX Technology
- Exchange
- PMCB Nasdaq
- FRSX Nasdaq
- Market Cap
- PMCB 11.4M
- FRSX 12.6M
- IPO Year
- PMCB N/A
- FRSX 2017
- Fundamental
- Price
- PMCB $1.22
- FRSX $0.68
- Analyst Decision
- PMCB
- FRSX
- Analyst Count
- PMCB 0
- FRSX 0
- Target Price
- PMCB N/A
- FRSX N/A
- AVG Volume (30 Days)
- PMCB 14.5K
- FRSX 72.8K
- Earning Date
- PMCB 03-17-2025
- FRSX 05-27-2025
- Dividend Yield
- PMCB N/A
- FRSX N/A
- EPS Growth
- PMCB N/A
- FRSX N/A
- EPS
- PMCB 1.29
- FRSX N/A
- Revenue
- PMCB N/A
- FRSX $436,000.00
- Revenue This Year
- PMCB N/A
- FRSX N/A
- Revenue Next Year
- PMCB N/A
- FRSX N/A
- P/E Ratio
- PMCB $0.93
- FRSX N/A
- Revenue Growth
- PMCB N/A
- FRSX N/A
- 52 Week Low
- PMCB $1.03
- FRSX $0.55
- 52 Week High
- PMCB $2.42
- FRSX $2.63
- Technical
- Relative Strength Index (RSI)
- PMCB 43.93
- FRSX 50.75
- Support Level
- PMCB $1.15
- FRSX $0.60
- Resistance Level
- PMCB $1.32
- FRSX $0.67
- Average True Range (ATR)
- PMCB 0.11
- FRSX 0.06
- MACD
- PMCB 0.02
- FRSX 0.01
- Stochastic Oscillator
- PMCB 65.52
- FRSX 71.11
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.